The first human clinical trial for a groundbreaking new drug that has the potential to turn off the gene that causes Huntington’s disease will get underway in Vancouver this year, says a University of B.C. researcher. Dr. Blair Leavitt, a professor in UBC’s department of medical genetics heading up the city’s part of the international clinical trial, said the drug has the potential to directly treat the underlying cause of Huntington’s disease.
Read more: http://ift.tt/1GQkalU
No comments:
Post a Comment